Mark was Executive Vice President of Portfolio Strategy at Juno Therapeutics, and Executive Vice President, Research and Development and Chief Medical Officer at Dendreon. Mark Frohlich joined Indapta Therapeutics in 2022.
Mark Frohlich is currently Chief Executive Officer at Indapta Therapeutics - View - Indapta Therapeutics org chart
Create your alert
to follow the career of Mark Frohlich.
Mark Frohlich has a Bachelor of Science in Economics and Electrical Engineering from Yale University in 1984 and a Doctor of Medicine from Harvard Medical School in 1990.
They have also studied at Yale University :
Find more alumni from Yale University
They have also studied at Harvard Medical School :
Find more alumni from Harvard Medical School
Do you need to know more about Mark Frohlich? More results.
Report an error
Update the org chart details of Mark Frohlich.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.